One pill to tackle two problems: diabetes and cholesterol
NCT ID NCT04602754
First seen Jan 06, 2026 · Last updated Jun 22, 2026 · Updated 26 times
Summary
This Phase 3 trial tests a new combination pill called Berlim 25/20 for people with type 2 diabetes and high cholesterol. The study aims to see if the pill lowers blood sugar and bad cholesterol better than current treatments. About 228 adults will take part, and researchers will also monitor for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA ASSOCIATED WITH TYPE II DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Allergisa
RECRUITINGCampinas, São Paulo, Brazil
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Berlim 25/20 (a combination of empagliflozin and rosuvastatin)
What this could lead to
If successful, this could offer a single-pill option to manage both blood sugar and cholesterol in people with type 2 diabetes.
What could go wrong
This is a Phase 3 trial, so results are not yet confirmed. The benefits may not apply to all patients, and side effects are possible.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.